STAT Plus: U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine
The USPTO has removed a legal adviser after she tweeted contentious remarks about AIDS activists' right to challenge a patent extension sought by Gilead.
No hay comentarios:
Publicar un comentario